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件为：SPG 膜孔径为 1.1 μm，跨膜压力为 100 KPa，连续相乳化剂 PVA 的浓度
















































Hepatocellular carcinoma (HCC) is a grave threat to human health. At present, 
surgical resection and chemotherapy are the main treatment methods for it. However, 
both of them are imperfect alternatives because of the low excision rate and high 
recurrence rate of surgical resection, and lack of targeting and high cytotoxicity to 
body of traditional chemotherapy drugs. So it is essential to explore a kind of safe,  
high-targeting and low toxicity treatment. Recently, ultrasonic microbubbles are 
attracting a great deal of attention due to its own features, and some results have been 
achieved about the effects for cancer treatment combining with ultrasound.  
Based on the achievements of previous work, this thesis optimizes the 
preparation condition of membrane emulsification method by orthogonal design, with 
HCPT being drug model and Polylactide (PLA) being shell material. We get spherical 
drug- loaded microbubbles with suitable particle size, high-drug loading content and  
entrapment efficiency, then the effects of drug- loaded microbubbles combining with 
ultrasound treatment method to inhibit tumor are evaluated in vitro and in vivo, by 
MTT essay and animal experiments,respectively.  
The contents are summarized as follows: 
1. Preparation of HCPT-loaded ultrasonic microbubbles 
Three levels were selected from the influencing factors of microbubble shape, 
drug loading (DL) and entrapment efficiency (EE) based on the single- factor test, 
which are SPG membrane pore size, transmembrane pressure, the concentration of 
emulsifier, the volume ratio of dispersed phase and continuous phase. Then we 
arranged the orthogonal experiment as L9(3
4) table to establish the best preparation 
condition with DL and EE as two factors. The optimum condition of preparing 
HCTP-loaded microbubble by the membrane emulsification is as follows: SPG 
membrane with 1.1 μm pore size was chosen, transmembrane pressure was 100 KPa, 
the concentration of PVA in continuous phase was 1%,and the ratio of dispersed phase 
















2. Characterization of HCPT-loaded ultrasonic microbubble  
The obtained HCPT-loaded microbubbles by the optimized recipes and 
preparation technique was examined and characterized in many ways, including shape, 
particle size, drug loading, entrapment efficiency and morphology of HCPT in 
microbubbles. Results showed that they are regular sphere with smooth surface, 
specific diameters about 4μm, and outstanding monodisperse. The drug content and 
encapsulation efficiency can reach 1.62% and 65.5% respectively, and the results 
showed satisfactory reproducibility XRD paterns displayed that HCPT was 
amorphous state in drug- loaded ultrasound microbubbles. In addition we studied its 
release profile in vitro, which indicated that compared with free drugs, the 
microbubble preparations displayed favourable release behavior, and it could be better 
when ultrasound irradiation was added. 
3. The antitumor effect of HCPT-loaded microbubble combined with ultrasound 
The inhibition rate of cell proliferation in vitro and tumor growth inhibition 
effect in vivo were investigated by MTT essay with Bel-7402 hepatoma cell as object 
and animal experiment in which H22 solid tumor mice was introduced as the model. 
The results suggested that both in vitro and in vivo, HCPT-loaded microbubbles had 
dose-dependent inhibitory effects, and at the same dosage the inhibition effect of 
HCPT-loaded microbubbles was higher when combing with ultrasound (P<0.01). 
Furthermore this kind of treatment can decrease side effects of HCPT . 
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第一章  绪  论 
1.1 10-羟基喜树碱简介 
10-羟基喜树碱 (10-hydroxy-camptothecin HCPT) 是从我国特有植物喜树
(camptotheca acuminate) 的皮和果实中分离得到的 20 多个单体中抗瘤作用最强
的生物碱[1]，是制备其他喜树碱类衍生物药品的重要中间体，目前该生物碱是唯





    10-羟基喜树碱 (HCPT) 是一种黄色粉末或柱状结晶型粉末，遇光易变质，





环之间有共轭系统，其中 A 和 B 为喹啉环，C 为吡咯酮环，E 是一个具有手性
碳的六元 α-羟基内酯环结构。喜树碱类似物的构效关系研究表明，E 环上的 α-





低[9]。在 37℃且 pH7.4 的人血浆中，HCPT 半衰期仅为 11 min，平衡时内酯结构



















图 1.1 HCPT 的分子结构图 
Fig. 1.1 Configuration of 10-hydroxycamptothecin 
 
 
图 1.2 酸碱条件下 HCPT 内酯环形式(右)与羧酸盐形式(左)的平衡 
Fig. 1.2 The balance between HCPT lactone form(right) and carboxylic acid salt form 
(left) under different pH conditions 
 
HCPT 是 DNA 拓扑异构酶Ⅰ抑制剂[11,12]。TOPOⅠ是生物体内广泛存在的一
类必需酶，影响 DNA 拓扑结构[13],在 DNA 复制、转录和重组中均起着重要作用，
由于癌细胞中 TOPO I 含量比正常细胞高得多，所以更易遭受 TOPO I 抑制剂的
作用，从而达到杀死癌细胞的目的。实验研究表明，HCPT 属于细胞周期特异性



















HCPT 是一种很有发展前景的抗肿瘤药物，目前 HCPT 用于临床的制剂主要



































































































图 1.3 传统药物制剂和缓控释制剂给药系统的血药浓度变化 
Fig. 1.3 Schematic diagram of drug concentration changes in blood after taking 
the traditional doses and sustained-release and controlled-release drug delivery 
systems 
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